SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,102,123 | -22.9% | 1,182,168 | +3.3% | 0.75% | -18.4% |
| Q2 2023 | $5,318,954 | +4.7% | 1,143,861 | +4.0% | 0.92% | -16.6% |
| Q1 2023 | $5,082,176 | -27.4% | 1,100,038 | +27.0% | 1.10% | -40.7% |
| Q4 2022 | $6,997,078 | +83.4% | 865,975 | +26.0% | 1.86% | +71.7% |
| Q3 2022 | $3,815,000 | +297.0% | 687,335 | +272.5% | 1.08% | +206.5% |
| Q2 2022 | $961,000 | -41.5% | 184,518 | -7.7% | 0.35% | -26.4% |
| Q1 2022 | $1,643,000 | -50.1% | 199,846 | -9.7% | 0.48% | -33.7% |
| Q4 2021 | $3,292,000 | +6.7% | 221,219 | +35.4% | 0.73% | -7.0% |
| Q3 2021 | $3,086,000 | +1.6% | 163,389 | 0.0% | 0.78% | +17.6% |
| Q2 2021 | $3,037,000 | -34.2% | 163,389 | -19.4% | 0.66% | -38.0% |
| Q1 2021 | $4,613,000 | -20.3% | 202,696 | -24.0% | 1.07% | -27.8% |
| Q4 2020 | $5,789,000 | +174.2% | 266,645 | +27.0% | 1.48% | +165.3% |
| Q3 2020 | $2,111,000 | – | 210,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |